compartment where tPA is known to exacerbate brain damages. This alteration of tPA clearance after alcohol consumption is correlated with a selective, tissue-specific reduction of the levels of hepatic low-density lipoprotein receptor-related protein 1 (LRP-1, receptor implicated in the clearance of tPA 17, 18 ). Thus, we uncover here a critical role of the liverbrain axis in the beneficial effects of thrombolysis after stroke.
Methods
The complete details of methods used are described as online-only Data Supplement.
Ethanol Administration
Mice were housed with food and water (control group) or a 10% (v/v) alcohol solution (alcohol group) ad libitum access for 6 weeks. The average daily liquid intake was similar between both groups. Table I in the online-only Data Supplement shows body, brain, and liver net and relative weights of control and alcohol-exposed mice. We found no differences between control-and alcohol-exposed mice in any of these parameters.
Thromboembolic Focal Cerebral Ischemia and tPA-Induced Thrombolysis
We used the in situ thromboembolic stroke model consisting in injecting thrombin into the middle cerebral artery and followed by thrombolysis by tPA, as performed in the clinical setting. Brain lesion volumes were measured by magnetic resonance imaging analyses and regular thionine stainings.
Results

Alcohol Consumption Impairs the Beneficial Effect of tPA-Induced Thrombolysis After Stroke
We first investigated the impact of 6 weeks of alcohol consumption on postischemic outcome. We have formerly developed a model of focal thromboembolic stroke, which mimics several aspects of the clinical management of patients with stroke. In this model, the coagulation cascade is activated by the administration of thrombin, which triggers a fibrin-rich thrombus in the middle cerebral artery, which is spontaneously dissolved in the following hours by the endogenous fibrinolytic system, 19 mimicking the human pathology. 20 In addition, thrombolysis performed as for patients with stroke (10% bolus and 90% infusion >1 hour) also has a therapeutic window, with early recanalization being beneficial but not if performed too late. 21, 22 Whether thrombin exerts specific effects on the neurovascular unit 23, 24 beside clot formation in this model remains to be established.
This model was thus induced in control-or alcohol-exposed mice (ad libitum access to 10% alcohol solution for 6 weeks). Twenty minutes after stroke onset, tPA or saline were intravenously injected. Four groups were thus considered: control-saline (nonthrombolysed), control-tPA (thrombolysed), alcohol-saline (nonthrombolysed), and alcohol-tPA (thrombolysed). We performed a longitudinal study to measure cerebral lesions at both early (2 hours and 30 minutes; Figure 1A and 1B) and late (24 hours, Figure 1C and 1D) time points after ischemic stroke onset in control (no alcohol) and alcoholexposed mice, treated or not by tPA. At 2 hours and 30 minutes post ischemic onset, MR diffusion-weighted imaging lesion volumes were already significantly bigger in nonthrombolysed mice exposed to alcohol (+115%) versus nonthrombolysed control mice (P<0.05; Figure 1A and 1B). At this early time, thrombolysed mice displayed smaller infarcts than nonthrombolysed mice, although the difference did not reach statistical significance for control mice ( Figure 1A and 1B) .
About lesion volumes measured 24 hours post stroke onset ( Figure 1C and 1D ), brain damages were still significantly higher in nonthrombolysed alcohol-exposed mice than in nonthrombolysed control mice (+78%; P<0.05).
However, although tPA-induced thrombolysis significantly reduced ischemic lesion volumes in control mice (−61.3% versus nonthrombolysed control mice; P<0.05), we observed that the initial beneficial effect of tPA-induced thrombolysis disappeared in mice exposed to alcohol. Noteworthy, the lesion volume because of progression between 2 hours and 30 minutes and 24 hours (ie, the difference between the lesion volume at 24 hours and 2 hours and 30 minutes) is 7.6-fold higher in alcohol-exposed mice receiving tPA than in control mice receiving tPA (15.36 versus 2.02 mm 3 , respectively). We studied brain perfusion after stroke onset and did not observe any modification after alcohol consumption ( Figure I in the online-only Data Supplement), showing no evidence of microvascular injuries which could aggravate ischemic lesion in this model, in accordance with previous works. 25 Besides, none of the animals, whatever the treatment, displayed intracerebral hemorrhage or significant edema (measured as the volume of the ipsilateral over the contraleral hemispheres on thionin-stained sections). The lack of significant bleeding transformations is consistent with preclinical and clinical data, reporting a low percentage of hemorrhages in patients with stroke treated in the therapeutic window of tPA and suggesting that if tPA is administered soon enough after stroke, it does not increase the risk of bleeding. [26] [27] [28] Moreover, we studied the effect of alcohol on the blood-brain barrier (BBB) and we observed that alcohol did not alter significantly the extent of BBB leakage ( Figure II in the online-only Data Supplement).
Our results show that tPA-induced thrombolysis loses its beneficial effect after alcohol consumption in mice.
Our Model of Alcohol Consumption Does Not Modify Clotting Time, tPA Endogenous Levels and Activity, or the Fibrinolytic Efficiency of Exogenous tPA
We wanted to determine whether the loss of efficacy of brain protection in case of thrombolysis following stroke after alcohol consumption could be because of differences in the fibrinolytic efficiency of exogenous tPA ( Figure III in the online-only Data Supplement). Doppler flowmetry, magnetic resonance imaging angiographic scores, in vitro clot lysis assays, enzyme-linked immunosorbent assay, and amidolytic activity assays converge to show that the loss of protection of thrombolysis in alcohol-exposed mice is not because of alterations of neither exogenous nor endogenous fibrinolytic activities.
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There was no modification in liver weight (Table I in the online-only Data Supplement) and no change in the activated partial thromboplastin time, factor VII, antithrombin, or hematocrit between control and alcohol-exposed mice ( Figure IV in the online-only Data Supplement). We observed that total plasmatic and hepatic mRNA PAI-1 levels are significantly reduced after alcohol consumption (P<0.05). Besides, we postulated that this incipient dysfunction of the liver could impair tPA clearance, which is known to be mediated by LRP-1 and mannose receptors. 17, 29 The mannose receptor expression levels were similar in the liver or the brain of control and alcohol-exposed mice ( Figure V in the online-only Data Supplement). However, quantitative real-time PCR (n=4; P<0.05; Figure 2A ), immunoblottings (n=4; P<0.001; Figure 2A ), and immunohistochemistry (n=3; P<0.05; Figure 2B ) revealed a significant hepatic reduction of the expression of LRP-1. The reduction in LRP-1 levels is selective of the liver because we detected no changes in its mRNA expression (n=4; Figure 2C ) or protein levels (n=4, Figure 2C ; n=3, Figure 2D ) in the brain cortex.
Delayed Hepatic tPA Clearance After Alcohol Consumption
We investigated whether the lack of efficacy of tPA treatment in alcohol-exposed mice was correlated with a modification of its bioavailability. Alexa 555 -labeled tPA (tPA 555 ) was injected intravenously in control and alcohol-exposed mice, and blood samples were harvested at different times post injection (n=3 mice per group; Figure 3A ) and subjected to SDS-PAGE to quantify fluorescent tPA ( Figure 3A) . To avoid the saturation of tPA 555 fluorescent signal, we injected a low dose of B, Quantification of lesion volumes 2h30 after stroke onset (n=7-8 mice per group; *P<0.05; **P<0.01). At 2h30 post ischemic onset, lesion volumes were already significantly higher in nonthrombolysed mice exposed to alcohol for 6 weeks. C, Representative histological analyses taken at 24 hours post ischemic onset. D, Quantification of lesion volumes 24 hours after stroke onset (n=7-8 mice per group; *P<0.05). Final lesion volumes were significantly higher in alcohol-exposed mice. tPA-induced thrombolysis reduced ischemic lesion volumes in control mice, whereas it lost its beneficial effect in mice exposed to alcohol. by guest on April 12, 2017 http://stroke.ahajournals.org/
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June 2015 tPA 555 (0.5 mg/kg). Although in control mice, the level of tPA 555 peaked at 5 minutes post injection and came back to the baseline after 15 minutes, in alcohol-exposed mice, the levels of tPA remained elevated until 15 minutes post injection, and then returned to the baseline after 30 minutes ( Figure 3A ; P<0.05). During the hour after tPA intravenous injection, the quantity of plasmatic tPA (total area under the curve) in alcohol-exposed mice was almost twice bigger than in control mice ( Figure 3A ; P<0.05). In another series of experiments, we tested whether the tPA injected under the same conditions of thrombolysis (10 mg/kg, IV) was enzymatically active or not (n=4 mice per group; Figure 3B ). Thirty-five minutes after the injection, we observed that the amidolytic activity of tPA in alcohol-exposed mice was significantly higher than in control mice (23% increase; P<0.05; Figure 3B ). Altogether, these results demonstrate that tPA not only remains longer in the bloodstream after a 6-week alcohol exposure, but that this tPA is still enzymatically active.
Because tPA is mainly cleared from the blood by the liver, 17 we performed a series of experiments to study real-time tPA 555 hepatic clearance using in vivo 2-photon microscopy (n=3 mice per group; Figure 3C ). To stain blood vessels, we injected fluorescein isothiocyanate-dextran (green fluorescence; top panels), which is not recaptured by the liver between 0 and 60 minutes ( Figure 3C , top panels). After a first acquisition (before injection panels), tPA 555 (red fluorescence) was intravenously injected and images of the liver were captured at different time points. In control mice, 5 minutes after injection, tPA 555 has already started to enter into the liver parenchyma, and after 10 minutes, tPA 555 was almost exclusively present in the parenchyma ( Figure 3C ; tPA 555 and merged panels). By contrast, in alcohol-exposed mice, tPA 555 was still present in the blood vessels 10 minutes after its injection, and its passage into the liver parenchyma was notably decreased at every time point ( Figure 3C ; tPA 555 and merged panels). In the second set of experiments, we performed immunohistological analyses in saline-perfused livers of control-and alcohol-exposed mice 60 minutes after tPA 555 injection. We detected a significant decrease in tPA 555 levels in the liver of alcohol-exposed mice (n=3 mice per group; Figure 3D ). This decrease in hepatic tPA 555 fluorescence in alcohol-exposed mice at 60 minutes matches with the decrease observed by in vivo 2-photon microscopy at the same time point in alcohol-exposed mice ( Figure 3D ; t=+60-minute panels). All these results clearly indicate an inefficient clearance of tPA by the liver of alcohol-exposed mice. ) plasmatic levels 15 minutes after tPA 555 intravenous injection (0.5 mg/kg) and quantification of electrophoresis gels (A). Fifteen minutes after tPA 555 injection, alcohol-exposed mice showed significantly higher blood tPA levels than control mice (n=3 samples per group; *P<0.05). Area under the curve measuring total tPA 555 in the bloodstream of control and alcohol-exposed mice during 60 minutes after tPA 555 intravenous injection (A; n=3 per group). Amidolytic activity of tPA injected at the same dose as in thrombolysis (10 mg/kg, IV), which is significantly increased after alcohol exposure (B; n=4 samples per group; *P<0.05). The clearance of tPA by the liver is dramatically reduced after alcohol consumption (C). Two-photon microscopy showing real-time hepatic clearance of tPA 555 in control and alcohol-exposed mice. Blood vessels are visualized in green by fluorescein isothiocyanate (FITC)-dextran, before tPA 555 injection. In control mice, after its intravenous injection (t=0), tPA 555 rapidly begins to enter into the liver parenchyma (t=+5 minutes; tPA 555 and merged photomicrograph), and its passage into the liver parenchyma is practically achieved at t=+10 minutes (merged photomicrograph). However, after alcohol consumption, the passage of tPA 555 into the liver parenchyma is delayed and inefficient: tPA 555 is still present in the blood vessels 10 minutes after its injection, and its passage into the liver parenchyma is notably decreased at all the time points t=+20 minutes, t=+30 minutes, t=60 minutes (tPA 555 and merged panels; n=3 mice per group). Immunohistological representative images of saline-perfused mice showing significantly less Alexa 555 -labeled tPA in the liver parenchyma of mice exposed to alcohol than in the liver of control mice (D) and quantification. Data are expressed as mean±SEM, and normalized versus control group (n=3 samples per group; *P<0.05). DAPI indicates 4′,6-diamidino-2-phenylindole. ) as a control (Figure 4) , in control and alcohol-exposed mice. In control mice, tPA 680 was detected almost exclusively in the liver, with only a weak amount of tPA 680 in the brain tissue (n=5; Figure 4A-4D) . Strikingly, tPA 680 levels were dramatically lower in the liver of alcohol-exposed mice and were dramatically increased in the corresponding brain parenchyma (n=5; Figure 4A and 4B; 6-fold increase versus control mice; P<0.001). Using albumin 680 as a control (same molecular weight than tPA), we did not found any difference between alcohol-exposed and control mice ( Figure 4C and 4D) . These results show that a 6-week alcohol exposure reduces the hepatic clearance of tPA, leading to an increased passage of tPA into the brain parenchyma.
Prolonged Presence of tPA in the Bloodstream Favours Ischemic Damages
Control mice were in vivo transiently transfected with a plasmid containing the tPA sequence (tPA-pLive) to experimentally increase circulating tPA levels, thus mimicking the impact of thrombolysis after a 6-week alcohol exposure. Three days after transfections, basal levels of active tPA in the liver and plasma were higher in tPA-pLive transfected mice than in control mice (transfected with an empty-pLive plasmid; Figure 5A ). At that time, experimentally induced ischemic lesions were bigger in tPA-pLive transfected mice than in empty-pLive transfected mice (1.7-fold increase, P<0.001; n=7 mice per group; Figure 5B) .
In an additional series of experiments, we injected increasing doses of tPA to mimic the plasmatic increase in tPA found after 6 weeks of alcohol exposure. Whereas the standard thrombolytic dose of tPA in mice (10 mg/kg) significantly reduced infarct volume, tPA at 20 mg/kg was not beneficial and did not reduce brain lesions (P<0.05; n=8-10 mice per group; Figure 5C ).
Altogether, our data show that (1) thrombolysis is not beneficial after a 6-week alcohol exposure; (2) plasmatic tPA levels remain elevated longer after alcohol exposure because of a selective impairment of the efficacy of tPA clearance by hepatic LRP-1; (3) high levels of circulating tPA worsen ischemic brain damages. The increase in the bioavailability of tPA could increase its ability to cross the BBB; to reach the brain parenchyma, and consequently to unmask the deleterious effect of tPA in the brain parenchyma ( Figure 6 ). We thus propose that an efficient liver-brain axis warranties the safety of thrombolysis after stroke.
Discussion
Here, we analyzed the consequences of a 6-week alcohol exposure on the risk/benefit ratio of tPA-induced thrombolysis during ischemic stroke in mice. To our knowledge, this is the first demonstration of a loss of benefit of tPA-mediated thrombolysis after alcohol consumption. Overall, our data suggest that this noxious effect of alcohol consumption results from the following mechanistic cascade: (1) alcohol consumption downregulates the expression of LRP-1 selectively in the liver; (2) this is correlated with an inefficient clearance of tPA by the liver; (3) eventually, the bioavailability of tPA is increased during thrombolysis, which facilitates its passage into the brain parenchyma, where it is known to promote BBB leakage and neurotoxicity. To our knowledge, this is the first report showing the influence of the liver capacity to control tPA bioavailability on the beneficial effects of thrombolysis.
As reported in rats subjected to transient focal ischemia in rats, 13 we found that 24 hours post stroke onset, mice exposed ), clearance of tPA was achieved and fluorescence was present almost exclusively in the liver (A) and almost no fluorescence was detected in the brain (B). By contrast, in alcohol-exposed mice, almost no fluorescence was detected in the liver (A), whereas fluorescence present in the brain was significantly higher than in control mice (B). These effects were specifically restricted to tPA 680 because fluorescent albumin 680 levels were similar in the liver (C) and the brain (D) of control and alcohol-exposed mice (n=5 mice per group; *P<0.05).
by guest on April 12, 2017 http://stroke.ahajournals.org/ Downloaded from to alcohol showed bigger lesions than control mice. In addition, our longitudinal study shows that alcohol consumption speeds up the evolution of ischemic lesions, since 2 hours and 30 minutes after stroke onset, mice exposed to alcohol already showed higher lesion volumes than control mice. Interestingly, a recent clinical study 10 has shown that chronic ethanol consumption is associated with higher baseline stroke severity in patients with ischemic stroke. Strikingly, our results show that although tPA-driven thrombolysis is highly efficient in protecting the brain in control mice (60% protection), it loses its Figure 5 . Experimental increase in plasmatic tissue-type plasminogen activator (tPA) levels provokes higher ischemic lesions. A, Three days after hydrodynamic transfections, active tPA was present in the plasma of tPA-pLive transfected mice, whereas no tPA was found in the plasma of emptypLive transfected mice. B, Representative histological analyses acquired at 24 hours post ischemic onset in control mice (drinking water) transfected with empty-pLive and tPA-pLive and quantification of lesion volumes 24 hours after stroke onset. Ischemic lesions were significantly higher in tPA-pLive transfected mice than in empty-pLive transfected mice (n=7 mice per group; ***P<0.001). C, Experimental design to mimic the increase of plasmatic tPA found in the alcohol-exposed mice by the injection of tPA 20 mg/kg; magnetic resonance imaging (MRI) representative images 24 hours after stroke onset; quantification of infarct volume. The additional infusion of tPA to control mice results in the loss of the beneficial effect of tPA at the standard thrombolytic dose used in mice (n=8-10 mice per group; *P<0.05). Figure 6 . Proposed mechanism of alcohol-induced loss of beneficial effect of tissue-type plasminogen activator (tPA)-mediated thrombolysis. A, In case of ischemic stroke, administration of tPA (ie, thrombolysis) (1) permits the lysis of the clot on the blood vessel and thus the reperfusion of the ischemic brain territories (2) . When liver performance is unaltered (A), after its intravenous injection, tPA is rapidly recaptured by the liver (3) and its action is finished. B, However, in case of liver dysfunction (eg, after alcohol consumption for 6 weeks), we propose that there is an important decrease in liver lipoprotein receptor-related protein 1 (LRP-1) receptors (4) and thus tPA clearance drops off (5) . tPA might then remain longer in the bloodstream (6), tPA passage into the brain parenchyma could be facilitated (6) , and because of its neurotoxic effects on the brain parenchyma (7), tPA loses its beneficial effect.
by guest on April 12, 2017 http://stroke.ahajournals.org/ Downloaded from beneficial effect after alcohol consumption, despite effective recanalization. Moreover, the lesion volume because of progression between 2 hours and 30 minutes and 24 hours was 7.6-fold higher in alcohol-exposed mice receiving tPA than in control mice receiving tPA, suggesting a delayed deleterious effect of tPA in alcohol-exposed mice.
We show that the loss of benefit of thrombolysis after stroke in alcohol-exposed mice is not because of a decrease in the fibrinolytic capacity of tPA, since restoration of blood flow in the ischemic hemispheres was similar in both thrombolysed groups (as shown by Doppler flowmetry and angiographic score). Importantly, our study shows that the defective brain protection is related to an impaired liver function. Among the changes observed, our model of alcohol consumption modified hemostatic parameters (decreases in prothrombin time and factor V levels, increase in factor VIII levels, but no changes in liver weight). Platelet number was also decreased, which is in accordance with the reports showing that alcohol-related liver disease commonly courses with thrombocytopenia because of a direct effect of ethanol on platelet formation and lifespan. 30 Despite these altered hemostatic parameters and platelet number, we observed neither differences in the clotting time nor spontaneous hemorrhagic transformations after tPA administration between control and alcohol-exposed mice. Overall, this indicates that our protocol does not provoke strong liver dysfunctions because it does not trigger hemostasis impairment, which is known to occur in patients with severe liver disorders, 31 but rather provokes more subtle changes in liver function. This is in agreement with a recent comparison of different models of alcohol administration in animals 32 and opens interesting clinical issues, since our findings may in fact be translated to a significant portion of patients with stroke, as they relate to moderate drinkers, not heavy alcoholics.
Alcohol-induced alterations of other organs could also contribute to the fate of brain cells after stroke. 33 We have not address this in detail but in the study by Cook et al 34 , using a similar regimen of alcohol exposure (ad libitum access in the drinking water) but for a much longer period and with a 2-fold higher dose than ours, it was found that mice had reduced heart weight, mild steatosis, altered gut flora, increased serum levels of peptidoglycan, whereas many other parameters/ organs like alanine aminotransferase activity, pancreas, corticosterone or peripheral blood parameters were not altered.
Besides, we observed that total plasmatic PAI-1 levels are significantly reduced after alcohol consumption. This reduction in the plasmatic concentration of total PAI-1 is, at least partially, explained by a reduced expression of PAI-1 in the liver after alcohol exposure. 35, 36 Under normal conditions, tPA is efficiently cleared from the circulation by the liver and has a short half-life in the bloodstream (4-5 minutes). 37 This issue could raise the possibility that lower plasmatic levels of PAI-1 in alcohol-treated mice may participate in the clearance of tPA. However, this seems unlikely in our model because, although different in control and alcohol-treated mice, plasmatic levels of PAI-1 remain low (≈0.2 nmol/L) in both cases when compared with the plasmatic concentration of tPA reached during thrombolysis (≈300 nmol/L). Therefore, it is expected that tPA after intravenous injection mainly circulates not complexed to PAI-1 in both control and alcohol-treated mice. Thus, knowing that tPA clearance normally relies on LRP-1, 18 we also studied its expression levels in the liver, which interestingly, were dramatically decreased in alcohol-exposed mice. In parallel to reduced levels of hepatic LRP-1, we observed an increased bioavailability of exogenous, active tPA, with an impairment of tPA clearance by the liver: (1) exogenous tPA 555 remained longer in the blood of alcohol-exposed mice than in control mice and (2) in vivo 2-photon liver microscopy showed an inefficient passage of exogenous tPA 555 into the liver parenchyma after alcohol consumption. Our data add to previous observations in severe hepatic diseases (fibrosis or cirrhosis 38 ), showing that even subtle changes in hepatic function increase tPA plasmatic levels because of reduced clearance.
We hypothesized that this delayed tPA clearance by the liver after alcohol consumption could result in a deleterious increase of tPA passage into the brain parenchyma. In favor of this hypothesis, near-infrared fluorescence imaging showed that control mice show most of the fluorescence in the liver (and not in the brain), whereas alcohol-exposed mice showed most of the fluorescence in the brain (and not in the liver). Moreover, hydrodynamic transfections used to increase tPA expression in the plasma of control mice (not exposed to alcohol) led to higher ischemic lesions in tPA-pLive transfected mice than in empty-pLive transfected mice.
Another nonexclusive mechanism that could explain the loss of beneficial effect of tPA after alcohol consumption could result from the established hyperexcitability of the brain induced by alcohol consumption/withdrawal. 11 This latter is notably because of an increased expression and activity of N-methyl-D-aspartate receptors.
A limit to our findings is the lack of clinical observations supporting our hypotheses. Clinical evidence of the occurrence of tPA effects shown in animal models is challenging, but it is worth mentioning that after ischemic stroke, exogenous tPA was independently associated with seizure occurrence (a mechanism that involves tPA 39 ) and a worse outcome at 3 months in this seizure subgroup of patients. 40 In addition, brain imaging studies evidenced that exogenous tPA indeed promotes BBB leakage in patients with stroke. 41 About the impact of alcohol consumption, Takada et al actually reported that alcohol habit is associated with a good outcome after local intra-arterial thrombolysis. However, the term alcohol habit was not defined, and it is important to point out that the authors used urokinase, 15 another plasminogen activator which is known to be non-neurotoxic. 42 In addition, to our knowledge, no clinical data have directly demonstrated an impaired clearance of tPA in humans with liver dysfunction. However, tPA levels have been shown to be increased in the plasma of patients with liver disease and 2 hypotheses have been formulated: either an increased release of tPA from endothelial cells or a reduced hepatic clearance of tPA. 43 ,44
Conclusions
Our study shows that a 6-week alcohol exposure aggravates stroke lesions and that thrombolysis loses its beneficial effect after alcohol consumption. We propose that this loss of efficacy depends on the brain-liver connection in terms of tPA clearance and bioavailability. After alcohol consumption, the liver suffers a series of damages, including an impaired tPA clearance, which will profoundly affect stroke outcome, especially if the patient is thrombolysed. Increased circulating tPA levels (in both time and quantity) aggravate damages, possibly because of tPA's neurotoxic effects in the brain parenchyma. Altogether, our original data reveal the importance of the liver-brain axis in the chances of success of tPA-induced thrombolysis during stroke. Challenges like alcohol consumption can induce subtle liver dysfunction, may profoundly impact the outcome of thrombolysed-stroke patients. In our opinion, attention should be paid to the history of each stroke patient, in terms of liver capacity of tPA clearance.
